Sale!

DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B Genetic Test

Original price was: $700.Current price is: $500.

-29%

The DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B NGS Genetic DNA Test is a cutting-edge genetic analysis that identifies mutations in the DCTN1 gene responsible for distal hereditary motor neuropathy type 7B. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to detect specific genetic variations that cause progressive motor neuron degeneration affecting the peripheral nervous system. The test is crucial for individuals experiencing progressive muscle weakness, foot deformities, or those with family history of neurological disorders. Results provide valuable insights for early intervention, treatment planning, and genetic counseling. The test is available for $500 USD and offers reliable detection of hereditary motor neuron conditions with clinical accuracy.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B NGS Genetic DNA Test

Comprehensive Introduction to DCTN1 Gene Testing

The DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing methodology focuses on identifying mutations in the DCTN1 gene, which encodes dynactin subunit 1—a critical protein involved in intracellular transport within neurons. When mutations occur in this gene, they disrupt the normal function of motor neurons, leading to progressive degeneration and the development of distal hereditary motor neuropathy type 7B.

This condition belongs to a group of inherited neurological disorders characterized by progressive weakness and wasting of muscles in the hands, feet, and lower legs. The importance of this test cannot be overstated, as early detection enables proactive management strategies, genetic counseling for family planning, and potentially slows disease progression through targeted interventions.

What the Test Measures and Detects

Our NGS-based genetic test specifically targets and analyzes the DCTN1 gene for pathogenic variants that cause distal hereditary motor neuropathy type 7B. The test examines:

  • Point mutations, insertions, and deletions in the DCTN1 gene
  • Single nucleotide variants affecting dynactin function
  • Genetic markers associated with motor neuron degeneration
  • Inheritance patterns for autosomal dominant transmission
  • Specific variants linked to progressive peripheral neuropathy

The test utilizes state-of-the-art Next-Generation Sequencing technology, providing comprehensive coverage of the entire DCTN1 gene with exceptional accuracy and sensitivity. This advanced approach ensures reliable detection of even rare genetic variants that might be missed by conventional testing methods.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Progressive muscle weakness in hands and feet
  • Difficulty with fine motor skills and coordination
  • Foot deformities such as high arches or hammertoes
  • Muscle wasting in distal limbs without sensory loss
  • Family history of similar neurological symptoms
  • Unexplained progressive motor impairment
  • Early-onset peripheral neuropathy symptoms

At-Risk Populations

  • Individuals with family history of hereditary motor neuropathies
  • Patients presenting with progressive distal muscle weakness
  • Those with suspected inherited neurological disorders
  • Family members of diagnosed DCTN1 mutation carriers
  • Individuals planning pregnancy with neurological family history

Significant Benefits of DCTN1 Genetic Testing

Undergoing the DCTN1 Gene Neuronopathy test provides numerous advantages for patients and healthcare providers:

  • Early Diagnosis: Enables prompt identification of hereditary motor neuropathy before significant disability develops
  • Accurate Prognosis: Provides clear understanding of disease progression and expected clinical course
  • Family Planning: Offers crucial information for genetic counseling and reproductive decision-making
  • Targeted Management: Facilitates development of personalized treatment and rehabilitation strategies
  • Differential Diagnosis: Helps distinguish DCTN1-related neuropathy from other neurological conditions
  • Research Contribution: Contributes to ongoing scientific understanding of motor neuron diseases

Understanding Your Test Results

Positive Result Interpretation

A positive result indicates the presence of a pathogenic mutation in the DCTN1 gene. This confirms the diagnosis of distal hereditary motor neuropathy type 7B. Patients with positive results should:

  • Consult with a neurologist specializing in neuromuscular disorders
  • Undergo comprehensive neurological evaluation
  • Receive genetic counseling for family members
  • Develop a personalized management plan
  • Consider participation in relevant clinical trials

Negative Result Interpretation

A negative result suggests that no pathogenic DCTN1 mutations were detected. However, this does not completely rule out hereditary motor neuropathy, as other genetic causes may be responsible. Further evaluation may include:

  • Testing for other genes associated with similar conditions
  • Continued neurological monitoring
  • Consideration of alternative diagnoses
  • Regular follow-up with healthcare providers

Variant of Uncertain Significance

Some results may identify genetic changes whose clinical significance is currently unknown. In such cases, ongoing research and family studies may help clarify the variant’s importance over time.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Neurology and Genetics
  • Disease Category: Neurological Disorders

Pre-Test Requirements

Before testing, patients should provide:

  • Complete clinical history documentation
  • Participation in genetic counseling session
  • Detailed pedigree chart of affected family members
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer the DCTN1 Gene Neuronopathy Distal Hereditary Motor Type 7B NGS Genetic DNA Test across our extensive network of testing facilities throughout the United States. Our state-of-the-art laboratories and collection centers are conveniently located in major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and the Midwest
  • Houston and Texas metropolitan areas
  • Phoenix and Arizona regions
  • Philadelphia and the Northeast corridor
  • And many additional locations nationwide

Our comprehensive network ensures that patients can access this crucial genetic testing regardless of their location, with consistent quality standards and expert support at every facility.

Take Action Today

Don’t let uncertainty about neurological symptoms affect your quality of life. The DCTN1 Gene Neuronopathy test provides definitive answers and empowers you to make informed healthcare decisions. Our team of genetic specialists, neurologists, and certified genetic counselors are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or to speak with a genetic counseling specialist. Take control of your neurological health and gain the clarity you deserve with comprehensive DCTN1 genetic testing.

Early detection through genetic testing can significantly impact disease management and quality of life. Contact us now to begin your journey toward accurate diagnosis and personalized care.